04/07/2015 16:45:05 Free Membership Login

Exactech News (NASDAQ:EXAC)

DateTimeSource
Headline
06/25/201511:49AMBWExactech Receives FDA 510(K) Clearance for Its Optetrak Logic® Constrained Condylar Prosthesis
Clearance Welcome News for Knee Surgeons with Complex Revision Knee Arthroplasty Cases Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products for hip, knee, shoulder, spine and biologic materials, announced today it has received clearance from the U.S. Food and Drug Administration... More...>>
05/01/20158:10PMARNExactech Lowered to "Sell" at Zacks (EXAC)
http://tickerreport.com/banking-finance/493053/exactech-lowered-to-sell-at-zacks-exac/?utm_source=ADVFN&utm_medium=banner&utm_campaign=ADVFN More...>>
04/30/20153:43PMARNExactech Upgraded at Zacks (EXAC)
http://tickerreport.com/banking-finance/487521/exactech-upgraded-at-zacks-exac/?utm_source=ADVFN&utm_medium=banner&utm_campaign=ADVFN More...>>
04/30/20154:09AMARNCanaccord Genuity Lowers Exactech to Hold (EXAC)
http://tickerreport.com/banking-finance/484262/canaccord-genuity-lowers-exactech-to-hold-exac/?utm_source=ADVFN&utm_medium=banner&utm_campaign=ADVFN More...>>
04/28/20154:01PMBWExactech Q1 Revenue $61.4 Million. Net Income Down 2% to $4.1 Million. Diluted EPS $0.29 vs. $0.30.
Exactech, Inc. (Nasdaq:EXAC), a developer and producer of bone and joint restoration products for hip, knee, shoulder, spine and biologic materials, announced today revenue of $61.4 million for the first quarter of 2015, a 3% decrease from $63.3 million in the first quarter of 2014. On a constant currency basis, revenue... More...>>
04/22/20153:40AMARNExactech Rating Reiterated by Canaccord Genuity (EXAC)
http://tickerreport.com/banking-finance/465058/exactech-rating-reiterated-by-canaccord-genuity-exac/?utm_source=ADVFN&utm_medium=banner&utm_campaign=ADVFN More...>>
03/26/20159:45AMBWClinical Data on Exactech Technologies for Shoulder, Knee & Ankle Replacement Surgery Presented at the 2015 Orthopaedic Resea...
Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products for hip, knee, extremities, spine and biologic materials, presented scientific posters and presentations regarding its latest advancements for shoulder, knee and ankle replacement surgery during the 2015 Orthopaedic Research... More...>>
03/24/201510:03AMBWExactech Marks 30 Year Anniversary with Introduction of New Clinical Solutions for Improved Patient Outcomes at AAOS 2015 Ann...
Company Unveils Next Generation of ExactechGPS® and Cementless Option for Optetrak® Logic Knee, Launches Alteon® Brand of Hip Stems featuring Tapered Wedge Femoral Stem, Celebrates 10 Year Anniversary of Equinoxe® Shoulder System Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration... More...>>
02/17/20154:00PMBWExactech 2014 Revenue Up 5% to $248.4 Million, Net Income Up 7% to $16.5 Million, EPS $1.18; Q4 Revenue Up 3% to $63.3M, Net ...
Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products for hip, knee, shoulder and spine, announced today that revenue for 2014 increased 5% to $248.4 million from $237.1 million in 2013. Diluted earnings per share for the year was $1.18 based on net income of $16.5 million, representing... More...>>
02/03/20159:40AMBWExactech Schedules Fourth Quarter and Year End 2014 Earnings Release and Conference Call
Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products for hip, knee, shoulder, spine and biologic materials, will release its fourth quarter and year end 2014 financial results after the market closes on Tuesday, February 17th, 2015. A copy of the earnings release will be available... More...>>
01/20/20158:11AMBWExactech Acquires Industry-Leading Computer-Assisted Surgical Technology Company
Exactech Enhances R&D Competencies, Secures Exclusive Technology for ExactechGPS® -- Guided Personalized Surgery System Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products for hip, knee, shoulder and spine, announced today the acquisition of an industry-leading computer-assisted... More...>>
11/17/20148:08AMBWIndustry’s Fastest Growing Shoulder System Marks 10 Years of Improving Patient Outcomes
Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products for hip, knee, shoulder, spine and biologic materials, this week recognizes the 10th anniversary of its unique Equinoxe® Shoulder System. The Equinoxe system’s platform design enables surgeons to convert from either a primary... More...>>
11/11/20147:56AMBWExactech Launches Octane® Elevate Peek Spacer System For Lumbar Interbody Fusion Procedures
Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products for hip, knee, shoulder, spine and biologic materials, announces that its spine division has launched Octane® Elevate, a Poly Ether Ether Ketone (PEEK) spacer system, at the North American Spine Society Annual Meeting (NASS... More...>>
10/21/20144:00PMBWExactech Q3 Revenue Up 4% to $57.9 Million; Net Income Down 6% to $3.0 Million Due to Currency Losses; Q3 Diluted EPS $0.21 v...
Nine Months Revenue Up 5% to $185.1 Million; Net Income Up 5% to $11.4 Million or $0.81 EPDS Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products for hip, knee, shoulder and spine, announced today revenue of $57.9 million for the third quarter of 2014, a 4% increase over $55.7... More...>>
10/13/20144:50PMBWExactech Schedules Q3 2014 Earnings Release and Conference Call
Company Expects Q3 Revenue to be at Lower Range of Guidance and Earnings to Fall Below Guidance Due to Currency Impact Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products for hip, knee, shoulder, spine and biologic materials, will release its third quarter 2014 financial results... More...>>
10/09/201411:45AMBWExactech Innovations Presented at Recent Key Scientific Conferences
ICJR Transatlantic Congress Featured Pasquale Petrera, MD, on ExactechGPS® Guided Personalized Surgery Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products for hip, knee, shoulder, spine and biologic materials, recounted today the significant number of scientific posters and presentations... More...>>
08/13/20148:17AMBWExactech Announces First Implantation of New Alteon™ Tapered Wedge Femoral Stem
New Hip Replacement Design Targets Improvements for Hip Patients Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products for hip, knee, shoulder, spine and biologic materials, is proud to announce the first implantation of the Alteon™ Tapered Wedge Femoral Stem. The surgery took... More...>>
07/28/20144:05PMBWExactech Q2 Revenue Up 6% to $63.9 Million. Net Income up 12% to $4.2 Million. Diluted EPS $0.30 vs. $0.27.
Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products for hip, knee, shoulder and spine, announced today revenue of $63.9 million for the second quarter of 2014, a 6% increase over $60.6 million in the second quarter of 2013. Net income was $4.2 million, or $0.30 per diluted share... More...>>
07/10/20149:55AMBWExactech Schedules Second Quarter 2014 Earnings Release and Conference Call
Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products for hip, knee, shoulder, spine and biologic materials, will release its second quarter 2014 financial results on Monday, July 28th, 2014. A copy of the earnings release will be available at http://www.hawkassociates.com. The... More...>>
07/03/20148:17AMBWExactech Launches New Porous Technology for Total Knee Arthroplasty
Supporting Study to be Presented at European Orthopaedic Research Society Annual Meeting Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products for hip, knee, shoulder, spine and biologic materials, announced today the international launch of Optetrak Logic® Porous, a new porous... More...>>


Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

NYSE and AMEX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

1 site:2 us nasdaq exac150704 16:45